Bajen MT - Search Results

1

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).

Garcia-Tejedor A, Ortega-Exposito C, Salinas S, Luzardo-González A, Falo C, Martinez-Pérez E, Pérez-Montero H, Soler-Monsó MT, Bajen MT, Benitez A, Ortega R, Petit A, Guma A, Campos M, Plà MJ, Pernas S, Peñafiel J, Yeste C, Gil-Gil M, Guedea F, Ponce J, Laplana M. Garcia-Tejedor A, et al. Among authors: bajen mt. Front Oncol. 2023 Aug 9;13:1184021. doi: 10.3389/fonc.2023.1184021. eCollection 2023. Front Oncol. 2023. PMID: 37621686 Free PMC article.

2

[Simultaneous location of non-palpable breast neoplasms and sentinel node (SN) study by radioisotopic techniques].

Cortés M, Bajén MT, Gil M, Benito E, Moreno A, Gumà A, Ricart Y, Martin-Comín J. Cortés M, et al. Among authors: bajen mt. Rev Esp Med Nucl. 2005 Mar-Apr;24(2):101-6. doi: 10.1157/13071685. Rev Esp Med Nucl. 2005. PMID: 15745680 Spanish.

3

Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate.

Bajén MT, Benítez A, Mora J, Ricart Y, Ferran N, Guirao S, Carrera D, Gil M, Pla MJ, Gumá A, Palacin JA, Martin-Comin J. Bajén MT, et al. Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):338-43. doi: 10.1007/s00259-005-1931-8. Epub 2005 Nov 24. Eur J Nucl Med Mol Imaging. 2006. PMID: 16307292

4

[Influence of tumor location in patients with breast cancer on the sentinel node detection].

González-Soto MJ, Bajén MT, Pla MJ, Carrera D, Gil D, Benito E, Ricart Y, Roca M, Martín-Comín J. González-Soto MJ, et al. Among authors: bajen mt. Rev Esp Med Nucl. 2006 Mar-Apr;25(2):98-102. doi: 10.1157/13086251. Rev Esp Med Nucl. 2006. PMID: 16759615 Spanish.

5

Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.

Domènech A, Benitez A, Bajén MT, Pla MJ, Gil M, Martín-Comín J. Domènech A, et al. Among authors: bajen mt. Oncology. 2007;72(1-2):27-32. doi: 10.1159/000111085. Epub 2007 Nov 12. Oncology. 2007. PMID: 17998787

6

What are the preoperative factors that can determine the presence of metastases in other axillary nodes in breast cancer when the sentinel node is positive?

Domènech A, Benítez A, Bajén MT, Ricart Y, Rodríguez-Gasén A, Palacín JA, Català I, Gil M, Pernas S, García A, Martín-Comín J. Domènech A, et al. Among authors: bajen mt. Q J Nucl Med Mol Imaging. 2009 Aug;53(4):422-7. Epub 2008 Nov 28. Q J Nucl Med Mol Imaging. 2009. PMID: 19039302 Free article.

7

Removal of the internal mammary sentinel node in breast cancer.

Domènech-Vilardell A, Bajén MT, Benítez AM, Ricart Y, Mora J, Rodríguez-Bel L, García-Tejedor A, Climent J, López-Ojeda A, Urruticoechea A, Martín-Comín J. Domènech-Vilardell A, et al. Among authors: bajen mt. Nucl Med Commun. 2009 Dec;30(12):962-70. doi: 10.1097/MNM.0b013e328330addf. Nucl Med Commun. 2009. PMID: 19696690

8

Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.

Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, Benito E, Guma A, Gutierrez C, Pisa A, Urruticoechea A, Pérez J, Gil Gil M. Pernas S, et al. Among authors: bajen mt. Ann Surg Oncol. 2010 Mar;17(3):772-7. doi: 10.1245/s10434-009-0804-y. Ann Surg Oncol. 2010. PMID: 20183912

9

[Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women].

Bajén MT, Benítez AM, Domènech A, Ricart Y, Mora J, Notta P, Ramal D, Urruticoechea A, Soler T, Martín-Comin J. Bajén MT, et al. Rev Esp Med Nucl. 2010 Nov-Dec;29(6):289-92. doi: 10.1016/j.remn.2010.07.002. Epub 2010 Sep 15. Rev Esp Med Nucl. 2010. PMID: 20828880 Spanish.

10

Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?

Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, Perez-Montero H, Fernandez-Montolí E, Stradella A, Recalde S, Soler T, Petit A, Bajen MT, Benitez A, Guma A, Campos M, Pla MJ, Martinez E, Laplana M, Pernas S, Perez-Sildekova D, Catala I, Ponce J, Falo C. Garcia-Tejedor A, et al. Among authors: bajen mt. Breast Cancer Res Treat. 2021 Feb;185(3):657-666. doi: 10.1007/s10549-020-05970-2. Epub 2020 Oct 17. Breast Cancer Res Treat. 2021. PMID: 33068198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page